AFP surveillance
-
Upload
avinash-bhondwe -
Category
Education
-
view
6.111 -
download
1
description
Transcript of AFP surveillance
AFP Surveillance
Dr. Sunil A. Tore M.B.B.S., D.P.H.,D.H.A., M.I.P.H.A.
Immunization Officer, Pune Municipal Corporation
Date : 20.08.2010
Current scenario of Polio
Cameroun
WORLD - WILD POLIO VIRUS CASES - 2010577 CASES IN 15 COUNTRIES
Pakistan
Afghanistan
CountriesWild cases
2010
India 25
Afghanistan 12
Angola 16
Pakistan 31
Tajikistan 437
Senegal 18
Sierra Leone 1
Mauritania 5
Mali 3
Nigeria 6
Niger 2
DRC 2
Nepal 4
Liberia 1
Chad 14
Total 577
India
Senegal
Nigeria
Chad
Mauritania
Mali
Angola
Sierra Leone
Nepal
Tajikistan
Liberia
Niger
* data as on 27th Jul 2010
DRC
0
250
500
750
1000
1250
1500
1750
2000
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010*
Polio cases, India
P1 wild P3 wild
* data as on 30 Jul 2010
State P1 P3 Total
West Bengal 4 1 5
Jammu & Kashmir 1 0 1
Jharkhand 1 0 1
Maharashtra 1 0 1
Uttar Pradesh 0 10 10
Bihar 0 6 6
Haryana 0 1 1
Total 7 18 25
WPVs
Location of poliovirus by type, 2010*
Most recent virus14 June 2010
Murshidabad, West Bengal
* data as on 30 Jul 2010
State P1 P2 Total
Uttar Pradesh 0 2 2
Tamil Nadu 0 1 1
Total 0 3 3
VDPVs
Genetic linkages of WPV1 cases, 2010*
* data as on 3 July 2010
Genetically related to June 2009 strain in Saharsa district of Bihar
Genetically related to June 2009 strain in Khagaria district of Bihar
Genetically related to an imported Sept 2009 strain in Ludhiana district of Punjab
* data as on 30 Jul 2010
State P1 P3 Total
Bihar 38 79 117
Uttar Pradesh** 34 569 602
Delhi 3 1 4
Punjab 2 2 4
Jharkhand 2 0 2
Rajasthan 1 2 3
Haryana 0 4 4
Uttarakhand 0 4 4
Himachal Pradesh 0 1 1
Total 80 662 741
WPVs
Location of poliovirus by type, 2009
State P1 P2 Total
Assam 1 0 1
Bihar 0 3 3
Uttar Pradesh 1 16 17
Total 2 19 21
VDPVs
** One case reported mixture of P1 wild & P3 wild
1735
397
139212
1487
203127
62
648
83 75 807
0
250
500
750
1000
1250
1500
1750
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010*
Polio cases of type 1, India
Year
* data as on 30 Jul 2010
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Jan
2009
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Weekly incidence of WPV1 cases, India, 2009 – 10
Jan
2010*
Feb Mar Apr May Jun
* data as on 30 Jul 2010
Area of m OPV1
mOPV1
tOPV
WPV1 Polio cases, India
Jan 10 Feb 10 Mar 10
Apr 10
* data as on 30 Jul 2010
May 10 Jun 10
N=2 N=1 N=0
N=1N=2N=1
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Jan
2009
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Weekly incidence of WPV1 cases, Uttar Pradesh, 2009 – 10
Jan
2010*
Feb Mar Apr May Jun
* data as on 30 Jul 2010
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Jan
2009
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Weekly incidence of WPV1 cases, Bihar, 2009 – 10
2010*
Jan Feb Mar Apr May Jun
* data as on 30 Jul 2010
190
127
59
116
22 7 428
794
484
662
18
730
0
100
200
300
400
500
600
700
800
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010*
Polio cases of type 3, India
Year
* data as on 30 Jul 2010
0
5
10
15
20
25
30
35
40
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Weekly incidence of WPV3 cases, India, 2009 – 10
Jan
2009
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan
2010*
Feb Mar Apr May Jun
* data as on 30 Jul 2010
WPV3 Polio cases, India
Jan 10 Feb 10 Mar 10
Apr 10
* data as on 30 Jul 2010
May 10 Jun 10
N=14 N=2 N=0
N=1 N=0 N=1
0
5
10
15
20
25
30
35
40
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Weekly incidence of WPV3 cases, Uttar Pradesh, 2009 – 10
Jan
2009
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan
2010*
Feb Mar Apr May Jun
* data as on 30 Jul 2010
0
5
10
15
20
25
30
35
40
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Jan
2009
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Weekly incidence of WPV3 cases, Bihar, 2009 – 10
Jan
2010*
Feb Mar Apr May Jun
* data as on 30 Jul 2010
MAHARASHTRA – 2010Wild cases
MH-NSK-10-201 10/01/2010
P1 Wild Case
Idcode Donset
Spot map of AFP cases
Total Resident AFP cases - 1193
#
#
##
#
##S
S
SS
S
SS
##
#
#
#
#
###
#
#
#
#
SS
S
S
S
S
SSS
S
S
S
S
#
#
S
S#
##
#
#
#
#
S
SS
S
S
S
S
#
##
#
#
###
##
#
#
#
#
#
#
##
#
#
#
##
#
#
##
S
SS
S
S
SSS
SS
S
S
S
S
S
S
SS
S
S
S
SS
S
S
SS
#
##
#
# #
#
S
SS
S
S S
S#
#
#
#
#
## ##
#
#
SS
S
S
S
SS SS
S
S
#
##
##
###
##
# ##
##
##
S
SS
SS
SSS
SS
S SS
SS
SS
#
#
##
#
#
#
#
#
#
#
###
#
# #
#
#
#
#
#
#
##
#
#
#
#
#
#
#
##
#
#
#
#
S
S
SS
S
S
S
S
S
S
S
SSS
S
S S
S
S
S
S
S
S
SS
S
S
S
S
S
S
S
SS
S
S
S
S
#
####
#
#
#
### #
#
#
###
#
##
#
##
#
#
#
#
#
#
#
#
#
#
#
#
#
##
#
#
#
#
##
#
#
#
#
S
SSSS
S
S
S
SSS S
S
S
SSS
S
SS
S
SS
S
S
S
S
S
S
S
S
S
S
S
S
S
SS
S
S
S
S
SS
S
S
S
S
##
#
#
###
#
#
#
#
#
##
#
#
#
###
#
#
#
#
##
#
#
##
SS
S
S
SSS
S
S
S
S
S
SS
S
S
S
SSS
S
S
S
S
SS
S
S
SS
#
# #
# #
#
##
#
##
#
####
#
#
#
###
#
S
S S
S S
S
SS
S
SS
S
SSSS
S
S
S
SSS
S
#
#
##
###
#
#
#
#S
S
SS
SSS
S
S
S
S
#
##
##
#S
SS
SS
S
###
#
#
## ########
###
###
##########
#####
#####
##
###
##### ###
#####
###
#
#
#
######
####
#####
##
## #
######
#######
##### ########
####
######
####
##
#
#
###
###
########
##
##
###
#
########
######
#
### #####
#####
######
#####SSS
S
S
SS SSSSS SSS
SSS
SSS
SSSSSSSSSS
S SSSS
SSSSS
SS
SSS
S SSSS SSS
SSSSS
SSS
S
S
S
SSSSSS
SSSS
SSSSS
SS
SS S
SS SSSS
SSSS SSS
SSSSS SSSSSSSS
SSSS
SS SSSS
SSSS
SS
S
S
SSS
SSS
SSSSSSSS
SS
SS
SSS
S
SSSSSSSS
SSSSSS
S
SSS SSSSS
SSSSS
SSSSSS
SSSSS
#
##
##
##
#
#
#
#
#
#
#
#
#
#
#
#
#
#
##
##
#
#
#
##
#
###
##
#
#
##
#
##
#
#
# ###
#
# #
##
#
##
#
#
#
###
##
##
#
#
##
#
#
##
#
## #
#
#
#
#
# ##
##
##
#
#
#
#
#
#
#
#
##
#
#
#
#
#
#
#
#
#
#
#
#
# ##
#
##
#
##
#
#
#
##
# #
#
##
#
##
##
#
#
# #
#
##
#
##
#
##
##
#
#
#
#
#
#
###
##
#
#
#
#
#
###
#
#
#
#
#
##
#
#
#
# #
#
#
#
#
#
##
#
##
# #
#
##
##
#
##
##
#
##
##
#
#
#
##
##
##
## #
#
#
#
##
#
#
##
#
# #
#
#
#
#
#
#
#
#
##
#
#
#
##
#
##
#
##
#
#
##
#
##
#
S
S S
SS
SS
S
S
S
S
S
S
S
S
S
S
S
S
S
S
SS
SS
S
S
S
SS
S
SSS
SS
S
S
SS
S
SS
S
S
S SSS
S
S S
SS
S
SS
S
S
S
SSS
SS
SS
S
S
SS
S
S
SS
S
SS S
S
S
S
S
S SS
SS
SS
S
S
S
S
S
S
S
S
SS
S
S
S
S
S
S
S
S
S
S
S
S
S SS
S
SS
S
SS
S
S
S
SS
S S
S
SS
S
SS
SS
S
S
S S
S
SS
S
SS
S
SS
SS
S
S
S
S
S
S
SSS
SS
S
S
S
S
S
SSS
S
S
S
S
S
SS
S
S
S
S S
S
S
S
S
S
SS
S
S S
S S
S
SS
SS
S
SS
SS
S
SS
SS
S
S
S
SS
SS
SS
SS S
S
S
S
SS
S
S
SS
S
S S
S
S
S
S
S
S
S
S
SS
S
S
S
SS
S
SS
S
SS
S
S
SS
S
SS
S
#
#
#
##
#
#
#
#
#
#
#
##
##
## #
#
###
#
#
##
##
#
#
#
#
#
##
#
#
#
#
#
#
##
#
#
#
S
S
S
SS
S
S
S
S
S
S
S
SS
SS
SS S
S
SSS
S
S
SS
SS
S
S
S
S
S
SS
S
S
S
S
S
S
SS
S
S
S
#
#
#
#
#
##
##
#
#
#
#
#
#
#
##
##
#
#
#
# #
#
##
#
#
#
#
#
#S
S
S
S
S
SS
SS
S
S
S
S
S
S
S
SS
SS
S
S
S
S S
S
SS
S
S
S
S
S
S
#
##
# ##
#
##
###
##
#
#
##
#
#
#
#
#
##
##
#
S
SS
S SS
S
SS
SSS
SS
S
S
SS
S
S
S
S
S
SS
SS
S
##
#
#
###
#
# #
#
#
#
##
SS
S
S
SSS
S
S S
S
S
S
SS
#
#
#
#
#
##
##
##
#
#
#
#
#
#
#
#
#
#
#
#
#
##
#
#
#
#
#
S
S
S
S
S
SS
SS
SS
S
S
S
S
S
S
S
S
S
S
S
S
S
SS
S
S
S
S
S#
#
##
#
#
#
#
#
#
#
#
#
#
#
## #
#
#
#
#
#
#
# ##
#
#
#
#
# #
# #
# #
#
#
##
#
#
# #
#
##
###
#
##
#
##
#
#
#
#
#
#
S
S
SS
S
S
S
S
S
S
S
S
S
S
S
SS S
S
S
S
S
S
S
S SS
S
S
S
S
S S
S S
S S
S
S
SS
S
S
S S
S
SS
SSS
S
SS
S
SS
S
S
S
S
S
S
#
##
##
#
#
##
#
#
#
#
#
#
#
#
##
S
SS
SS
S
S
SS
S
S
S
S
S
S
S
S
SS
# ##
##
##
# ##
##
#
## #
S SS
SS
SS
S SS
SS
S
SS S
#
#
# #
##
##
#
#
##
#
#
#
#
##
S
S
S S
SS
SS
S
S
SS
S
S
S
S
SS
#
#
#
###
S
S
S
SSS
#
#
#
#
#
#
##
#
#
# #
#
#
##
#
S
S
S
S
S
S
SS
S
S
S S
S
S
SS
S
#
#
#
##
##
#
#
#
#
#
##
#
##
#
##
#
#
##
#
#
#
#
#
#
#
#
#
#
#
#
##
#
#
##
#
#
##
#
#
#
#
#
#
#
#
#
#
S
S
S
SS
SS
S
S
S
S
S
SS
S
SS
S
SS
S
S
SS
S
S
S
S
S
S
S
S
S
S
S
S
SS
S
S
SS
S
S
SS
S
S
S
S
S
S
S
S
S
S
#
#
##
#
# ## #
#
##
#
##
#
#
### #
##
#
#
#
#
##
#
##
#
#
# #
#
#
#
#
#
##
S
S
SS
S
S SS S
S
SS
S
SS
S
S
SSS S
SS
S
S
S
S
SS
S
SS
S
S
S S
S
S
S
S
S
SS
#
##
#
#
#
####
#
#
#
###
#S
SS
S
S
S
SSSS
S
S
S
SSS
S#
##
#
##
#
#
#
#
#
#
#
#
S
SS
S
SS
S
S
S
S
S
S
S
S
##
##
##
#
#
##
#
SS
SS
SS
S
S
SS
S#
#
#
##
#
#
#
# #
#
#
#
##
#
#
###
S
S
S
SS
S
S
S
S S
S
S
S
SS
S
S
SSS
#
#
#
##
#
#
#
###
#
#
##
#
##
#
#
#
#
#
# #
#
#
#
#
#
##
#
#
#
#
##
#
S
S
S
SS
S
S
S
SS S
S
S
SS
S
SS
S
S
S
S
S
S S
S
S
S
S
S
SS
S
S
S
S
SS
S
ANG
SLR
PNA
NSK YTL
GDL
JLG AMT
STR
BED NDD
BLD
CPRABD
THN
NGP
JLN
KLP
SNGRTG
LTR
DHL
OBD
RGD
PBN
AKL
HIN
WDH
NDB
GNA
SDG
WSM
BND
BMC
* As of Week 29, 2010
Cameroun
WORLD - WILD POLIO VIRUS CASES - 2010577 CASES IN 15 COUNTRIES
Pakistan
Afghanistan
CountriesWild cases
2010
India 25
Afghanistan 12
Angola 16
Pakistan 31
Tajikistan 437
Senegal 18
Sierra Leone 1
Mauritania 5
Mali 3
Nigeria 6
Niger 2
DRC 2
Nepal 4
Liberia 1
Chad 14
Total 577
India
Senegal
Nigeria
Chad
Mauritania
Mali
Angola
Sierra Leone
Nepal
Tajikistan
Liberia
Niger
* data as on 27th Jul 2010
DRC
AFP Rate
Less than 0.69
2 & Above
0.70 to 0.99
1 to 1.99
No data MH– 5.57 %
ANG
SLR
PNA
NSK YTL
GDL
JLG AMT
STR
BED NDD
BLD
CPRABD
THN
NGP
JLN
KLP
SNGRTG
LTR
DHL
OBD
RGD
PBN
AKL
HIN
WDH
NDB
GNA
SDG
WSM
BND
BMC
* As of Week 29, 2010
POLIO ERADICATION MILESTONES
1988 WHA RESOLUTION
2000 STOP VIRUS
TRANSMISSION
2005 CERTIFY GLOBAL
ERADICATION
2005/10 STOP POLIO
IMMUNIZATION
1988
350 000 cases
125 countries
Areas with Active Polio Transmission
POLIO ERADICATION STRATEGIES
BASED ON DISEASE KNOWLEDGE POTENT VACCINE . EFFECTIVE METHODS FOR THE
CONTROL OF POLIO.
The disease of poliomyelitis has a long history. The first example may even have been more than 3000 years ago. An Egyptian stele dating from the 18th Egyptian dynasty (1580 - 1350 BCE) shows a priest with a deformity of his leg characteristic of the flaccid paralysis typical of poliomyelitis.
.
POLIO
MOST VOLUNERABLE GROUP IS < 5YRS.
HIGH TRANSMISSION-JULY TO SEPTEMBER.
ROUTE OF TRANSMISSION-FAECO-ORAL ROUTE.
OVER CROWDING,POOR SANITATION, SLUMS FAVOURABLE CONDITIONS
INCUBATION PERIOD- 1 TO 2 WEEKS.
POLIO DISEASE
• IT IS A VIRAL INFECTION CAUSED BY AN ENTEROVIRUS –POLIO VIRUS
• THREE TYPES• TYPE-1—EPEDEMICS • TYPE-2---THIS IS THE FIRST SERO
TYPE TO DISAPPEAR.• TYPE-3--- PARALYSIS LESS
FREQUENT.
In 1928, Philip Drinker and Louis Shaw at Harvard Medical School introduced the iron lung to help individuals suffering from acute poliomyelitis. Polio impaired patients' ability to breathe by paralyzing the diaphragm and intercostal muscles; the iron lung provided relief in the form of artificial respiration. It consisted of a sealed chamber in which air pressure is alternately reduced and increased. The patient was placed in the chamber with his/her head emerging from a port at one end. Each cycle of vacuum within the chamber allowed their lungs to be filled with atmospheric air; subsequent increase of pressure forced exhalation of air from the lungs.
POLIO DISEASE
IT IS A VIRAL INFECTION CAUSED BY AN ENTEROVIRUS –POLIO VIRUS
THREE TYPES TYPE-1—EPEDEMICS TYPE-2---THIS IS THE FIRST SERO
TYPE TO DISAPPEAR. TYPE-3--- PARALYSIS LESS
FREQUENT.
WHY POLIO IS A CANDIDATE FOR ERADICATION ?
MAN IS THE ONLY RESERVIOR NO LONG TERM CARRIER STATE ROUTE OF TRANSMISSION IS FAECO-
ORAL HALF LIFE OF EXCRETED VIRUS IN
SEWAGE SAMPLE IN TROPICAL CLIMATE LIKE INDIA IS 48 HOURS.
POTENT AND EFFECTIVE VACCINE.
WHY OPV ?
ALSO KNOWN AS SABIN VACCINE POTENT LIVE VACCINE GIVES GUT IMMUNITY GIVES HERD IMMUNITY- INTERRUPT’s
TRANSMISSION CYCLE EASY TO ADMINISTER COST EFFECTIVE
FOUR KEY STRATEGIES FOR POLIO ERADICATION
RI-PROGRAMME [ UIP ] - 1985 MASS IMMUNIZATION(PPI) – 1995-96
CAMPAIGNS APF SURVEILLANCE - 1997 MOPING UP IN FOCAL AREAS
WHAT IS PULSE POLIO ?
TO IMMUNIZE ALL THE KIDS< 5YRS NATION WIDE ON A SINGLE DAY IN THE SHORTEST POSSIBLE TIME WITH OPV & THAT THE ENVIRONMENT WILL GET SATURATED WITH THE VACCINE VIRUS SO THAT IT WILL REPLACE THE WILD VIRUS AND THUS INTERUPT THE TRANSMISSION OF WILD VIRUS .
WHAT IS SURVEILLANCE ?
• IT IS A CONTINOUS SCRUTINY OF ALL ASPECTS OF OCCURRENCE & SPREAD OF DISEASE THAT ARE PERTINENT TO EFFECTIVE CONTROL.
• IT INCLUDES1. COLLECTION OF DATA2. ANALYSIS OF DATA3. INTERPRETATION OF DATA4. DISTRIBUTION OF RELEVANT DATA SO
THAT NECESSARY ACTION CAN BE TAKEN
AIM OF AFP SURVEILLANCE TO DETECT POLIO TRANSMISSION &
INTERRUPTION OF TRANSMISSION AFP CASE
POLIO CASE
RESERVOIR OF INFECTION [ 100 TO 1000 SUB CLINICAL CASES ]
CONTAINMENT MEASURES [ O.R.I. / MOP UP ]
GOAL OF AFP SURVEILLANCE
IDENTIFICATION OF ALL RESERVOIRS OF CIRCULATING WILD POLIO VIRUS
( THAT COULD BE POLIO ) BY DOCUMENTING ALL SUCH CASES,IT IS POSSIBLE TO SHOW THAT NONE OF THESE “POLIO-LIKE” CASES WERE CAUSED BY THE POLIO VIRUS,AND THAT POLIO IS NO LONGER PRESENT OR EXISTING.
WHY AFP SURVEILLANCE INSTEAD OF POLIO SURVEILLANCE ?
SURVEILLANCE OF A POLIO CASE ALONE IS NOT SUFFICIENT BECAUSE IT IS IMPOSSIBLEE TO PRECISELY IDENTIFY ALL CASES OF POLIO CLINICALLY DUE TO CONFUSING AND AMBIGUOUS CLINICAL SIGNS AND VARIABLE CLINICAL KNOWLEDGE & SKILLS OF DOCTOR.
CLINICALLY POLIO IN ACUTE STAGE, IS DIFFICULT TO DISTINGUISH FROM OTHER CAUSES OF ACUTE ONSET OF FLACCID PARALYSIS.-----
SURVEILLANCE OF ACUTE FLACCID PARALYSIS
STARTED IN 1997 OCTOBER ACHIEVED GLOBAL
BENCHMARKS IN MAY 1998 MAPPING OF POLIO CASES
MADE POSSIBLE LABS PROVIDING > 80%
RESULTS ON TIME GENETIC SEQUENCING
CAPACITY EXPANDED
WHAT IS AFP ?OLD DEFINITION
ANY CHILD AGE < 15 YRS HAVING ACUTE ONSET OF FLACCID PARALYSIS FOR WHICH NO OBVIOUS CAUSE SUCH AS SEVERE TRAUMA OR ELECTROLYTE IMBALANCE IS FOUND
IT INCLUDES-GBS,TM,TN,POLIOMYELITIS
The AFP Surveillance System
Hospitals Clinics
Investigation
Non-Polio AFP Polio AFP
Community
Causes of AFP
• Poliomyelitis• Gullain Barre Syndrome• Traumatic neuritis• Transverse Myelitis• Any other flaccid/lower motor
presentation
AFP case definition broadened
Consequences of missing the case of polio are more serious then occasionally including and “ambiguous’’ case, specially during the final stage of polio eradication.
Includes every case with • current flaccid paralysis
• History of flaccid paralysis in the current illness
• Boarder line and ambiguous case
• Transient weakness / paralysis
When too much polio is around…..
Non-AFP cases
Polio cases
AFP cases
Borderline AFP cases
Surveillance sensitivity is
adequate enough to detect 90% polio cases
Adequacy of surveillance
• Programme Monitoring indicators
1. Non polio AFP rate
2. Adequate stool specimen collection
Non Polio AFP Rate
Proportion of Non Polio AFP cases –
is the indicator of quality of surveillance.
More the no. of AFP cases reported –
better the quality of
surveillance
Non Polio AFP Rate
1 Non Polio AFP case in 1 Lakh children (0 to 15 Years) .
Pune District – 27 lakh (0 to 15 years) – 27 non Polio AFP cases expected
PMC - 10 Lakh (0-15 years) – 10 non Polio AFP cases expected
This is the lowest limit of this indicator – applicable to western countries
Non Polio AFP Rate
Non polio AFP rate = Reported AFP cases
Expected AFP cases
e.g. In PMC = 10
10
= 1
2005 = 23
10
= 2.3
This rate should be more then 2.
When to report AFP case
Immediately ( Just one phone call)
9689931339 / 9822912062 / 24487700
So that stool samples are collected within 14 days from onset of paralysis
Stool can be collected up to 2 months Case can be reported up to 6 month
of onset
WHAT TO REPORT
Any Case of Acute Flaccid Paralysis < 15 Yrs age
It May be Monoplegia,Paraplegia,Hemiplegia,Facial Palsy,or Any Trasient weakness.
Any case of Suspected Polio Clinically
Irrespective of any age
AFP SURVEILLANCE
STEPS FOR EACH AFP CASE1. CASE INVESTIGATION2. 2 STOOL SPECIMENS,COLLECTED 24
HOURS APART,AND WITHIN 14 DAYS OF ONSET OF PARALYSIS
3. SENT FOR CULTURES TO LAB TO ISOLATE POLIO VIRUS
4. ORI ACTIVITY & SEARCH FOR MORE AFP CASES IN THE AREA
5. 60 DAYS FOLLOW-UP EXAMINATION AFTER ONSET.
STOOL COLLECTION
2 STOOL SAMPLES, COLLECTED 24 HOURS APART
COLLECTED WITHIN 14 DAYS OF ONSET
APPROXIMATELY 8 gms OR ADULT’s THUMB SIZE
KEPT IN REFRIGERATOR( DO NOT FREEZ)
SEND IN REVERSE COLD CHAIN TO LAB WITH PROPER DOCUMENTATION
ADEQUATE SPECIMENS TWO SPECIMENS - COLLECTED 24 TO 48 HOURS APART - WITHIN 14 DAYS OF PARALYSIS ONSET SPECIMENS ARRIVING @ LAB - GOOD CONDITION - NO LEAKAGE - NO DESICCATION - IN COLD CHAIN - WITH APPROPRIATE DOCUMENTATION
OUTBREAK RESPONSE IMMUNIZATION
TARGET AGE- 0- 59 MONTH OLD CHILDREN
AFTER COLLECTION OF SPECIMENS
ONE ROUND OF H-T-H
WHOLE VILLAGE / URBAN WARD
IMMEDIATELY FOLLOWING AN AFP CASE
WHY ORI ?
CONTROL OF OUTBREAK ESPECIALLY IN UPSURGE OF EPIDEMIC CURVE
AVOID NEGATIVE CONSEQUENCES OF COMPLACENCY
TO PROTECT AGAINST OTHER POLIO VIRUS TYPES
INFORMATION FOR ACTION- MOTIVATES REPORTING SITES,OPPORTUNITY FOR ACTIVE CASE SEARCH
60 DAYS FOLLOW UP
EACH AFP CASE MUST BE FOLLOWED-UP AFTER 60 DAYS AFTER ONSET OF PARALYSIS TO DETERMINE IF THERE IS STILL A RESIDUAL PARALYSIS
FOR FOLLOW-UP, EXACT PERMANENT ADDRESS OF THE PATIENT SHOULD BE WRITTEN ON THE CIF @ THE TIME OF INITIAL INVESTIGATION.
Onset of paralysis
Investigation of suspected case (≤48 hours of report)
2 stool specimens
collected (≤14 days since onset
of paralysis)24 hours apart
Outbreak response
immunization additional case
finding
60-day follow-up exam
Specimens arrive at national
laboratory
Results reported
from national
laboratory
Poliovirus isolates send to regional
reference laboratory for intratypic differentiation
Final classification of the case by the expert committee (≤ 12 weeks since onset of paralysis)
Appendix 5 :Flow diagram of case investigation,
stool specimen collection andoutbreak response immunization
≤ 3 Days ≤ 24 Days
≤ 7 Days
WHAT IS NOT AFP ?
TRAUMA ISOLATED FACIAL NERVE PALSY HYPOKALAEMIA ACUTE RHEUMATIC FEVER CONGENITAL FLACCID PARALYSIS
CONDITIONS SOMETIMES PRESENTING WITH AFP
TUMOR ENCEPHALITIS HYPOKALEMIC PARALYSIS [ DUE TO
LOW SERUM POTASSIUM USUALLY REVERSIBLE ]
POTT’s DISEASE TB MENINGITIS OSTEOMYELITIS
AFP Reporting Network
Gen. Pract.Paediatrician Neurologist Physician
Dist. Hospital
Traditional Healer
MPW/ ANM
RH
PHC
Quack
DHO/MOH/SMO
State
WHO
Delhi
Data Flow
Reporting Units Districts
Districts State
States NPSU Delhi
Delhi WHO
Mondays
Tuesdays
Wednesdays
Thursday
Reporting Units
Reporting Units
Informers
PMC 39 141
PCMC 18 7
PUNE RURAL
43 139
Pune Dist 100 287
Reporting units – sending reports weekly regularly
Informers – whenever AFP case - Informs by phone
Aundh
Kasba peth
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Rd
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP Reporting Unit - PMC
Dhole Patil
V wada
76
62
90
80
36
70
7957
56
60
59
73 6365
67
71
68
64
61
74
82
7858
8175
6672
77
69 8349
54
5253
50
51
55
48
Total Reporting Unit - 39
Aundh
Kasba peth
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Rd
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP Informer - PMC
Dhole Patil
V wada
76
62
90
80
36
70
15257
151
60
150
116 117115
67
71
68
180198
144
179
83184
182
116
181
173
183
114113
124
122
118
119
123121
120
200
199
185 201
202
132
205197
147
146
145
70148
196
167166
165
164
105
168195
174170 169
171177
178
Total Informers Unit - 141
Aundh
Kasba peth
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Road
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP CASES YEAR – 2001 - PMC
Dhole Patil
V wada
AFP Case 06
Compatible Case 00
Hot Case 00
Wild Case 00
MH-PNA-01-029
MH-PNA-01-046,
MH-PNA-01-041,045
PMC 06
OTHER DISTRICTS
14
TOTAL CASES
20
MH-PNA-01-015
MH-PNA-01-025
Aundh
Kasba peth
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Road
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP CASES YEAR – 2002 - PMC
Dhole Patil
V wada
AFP Case 13
Compatible Case 00
Hot Case 00
Wild Case 00
MH-PNA-02-004,012
t
MH-PNA-02-011
MH-Bmc-02-073,PNA-044
MH-PNA-02-033,034,035,021,019
MH-PNA-02-013PMC 13
OTHER DISTRICTS
19
TOTAL CASES
32
MH-PNA-02-026
MH-PNA-02-038
Aundh
Kasba peth
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Road
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP CASES YEAR – 2003 - PMC
Dhole Patil
V wada
AFP Case 09
Compatible Case 00
Hot Case 00
Wild Case 00
MH-PNA-03-043,052Updated upto wk 38th
MH-PNA-03-58
MH-PNA-03-027,031,034,007
MH-PNA-03-026
PMC 09
OTHER DISTRICTS
30
TOTAL CASES
39
MH-PNA-03-041
Aundh
Kasba peth
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Road
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP CASES YEAR – 2004 - PMC
Dhole Patil
V wada
AFP Case 15
Compatible Case 00
Hot Case 00
Wild Case 00
MH-PNA-04-205
MH-PNA-04-016,213
MH-PNA-04-008,009
MH-PNA-04-013,202,215
MH-PNA-04-014,
MH-PNA-04-507PMC 15
OTHER DISTRICTS
31
TOTAL CASES
46
MH-PNA-04-025
MH-PNA-04-005,217
MH-PNA-04-201
MH-PNA-04-216
Aundh
Kasba peth
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Road
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP CASES YEAR – 2005 - PMC
Dhole Patil
V wada
AFP Case 23
Compatible Case 00
Hot Case 00
Wild Case 00
MH-PNA-05-117,128
MH-PNA-05-105,131,134
MH-PNA-05-107,111,115
MH-PNA-05-124,127,135
MH-PNA-05-149
MH-PNA-05-114,118
MH-PNA-05-119PMC 23
OTHER DISTRICTS
32
TOTAL PUNE
55
MH-PNA-05-109
MH-PNA-05-107,108,146,153
MH-PNA-05-150
MH-PNA-05-148
MH-PNA-05-137
Aundh
Kasba peth
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Road
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP CASES YEAR – 2006 - PMC
Dhole Patil
V wada
AFP Case 26
Compatible Case 00
Hot Case 00
Wild Case 00
MH-PNA-06-101,109,133,162
MH-PNA-06-129
MH-PNA-06-136,151
MH-PNA-06-007,122
MH-PNA-06-137,141,143,144,149,150
MH-PNA-06-145PMC 26
OTHER DISTRICTS
39
TOTAL PUNE
65
MH-PNA-06-121,160,161
MH-PNA-06-118,126,127,146,
153
MH-PNA-06-108,155
Aundh
Kasba peth
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Road
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP CASES YEAR – 2007 - PMC
Dhole Patil
V wada
AFP Cases 24
Compatible Case 00
Hot Case 00
Wild Case 00
MH-PNA-07-109,114,117,160,172
MH-PNA-07-123,,142
MH-PNA-07-111
MH-PNA-07-140
MH-PNA-07-134
MH-PNA-07-103,115,139,147
MH-PNA-07-107,121,137
PMC 24
OTHER DISTRICTS
49
TOTAL CASES
73
MH-PNA-113,135,151
MH-PNA-07-129,211
MH-PNA-07-152,171
Aundh
Kasba peth
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Road
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP CASES YEAR – 2008 - PMC
Dhole Patil
Dhan
AFP Cases 21
Compatible Case 00
Hot Case 00
Wild Case 00
MH-PNA-08-111,118,153
MH-PNA-08-155
MH-PNA-08-141
MH-PNA-08-122,142
MH-PNA-08-112,130,139
MH-PNA-08-136PMC 21
OTHER DISTRICTS
36
TOTAL CASES
57
MH-PNA-08-147
MH-PNA-08-107,109,157
MH-PNA-08-114
MH-PNA-08-104,105,138,144,146Dhankawadi 05 cases
Aundh
Kasba Vishram
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Road
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP CASES YEAR – 2009 – PMC
Dhole Patil
Dhan
AFP Cases 76
Compatible Case 00
Hot Case 00
Wild Case 00
MH-PNA-09-129,139165,169
MH-PNA-09-101,115,
MH-PNA-09-132,
MH-PNA-09-124,125,130,151,157,176
MH-PNA-09-105,113162,168,172
PMC 31
OTHER DISTRICTS
45
TOTAL CASES
76MH-PNA-09-102,107,146,133
IND-BI-KTH-09-087
MH-PNA-09-103,160
MH-PNA-09-148,140
MH-PNA-09-156
MH-PNA-09-141
MH-PNA-09-171
MH-SLR-09-016,
Aundh
Kasba Vishram
PC
Hadapsar
Sangamwadi
Yerawada
Ghole Road
Bibweewadi
Warje Karve Nagar
Karve Rd
Tilak Road
Sahakar nagar
Lohgaon Airport
KC
Bhavani peth
AFP CASES YEAR – 2010 – PMC UPTO 29TH WEEK
Dhole Patil
Dhan
AFP Cases 38
Compatible Case 00
Hot Case 01
Wild Case 00
MH-PNA-10-103
MH-PNA-10-001
PMC 11+3=15
OTHER DISTRICTS
23
TOTAL CASES
38
MH-PNA-10-109,136,138
MH-PNA-10-112MH-SLR-10-108MH-PNA-10-133
MH-PNA-10-102
MH-PNA-10-114120,KA-BEL-10-
008
MH-PNA-10-118,
MH-PNA-10-105
MH-PNA-124
MH-PNA-10-137
Expectations from General Practioners
Routine Immunization
Services
AFP Surveillance
Expectation from GP’s
• Immunization –
1. Insist for Zero dose OPV
2. Routine immunization
3. Pulse polio immunization
4. Observing VVM during all immunization activities
(to train nursing staff – for VVM & cold chain)
Expectation from GP’s
Surveillance –
1. Report AFP case immediately – Just telephone – 9689931339 / 9822912062 / 24487700 Dr. Sunil A. Tore
2. To give information of AFP case –whenever phone calls from WHO or PMC office
3. An issue of reporting of referred case to neurologist for EMG/NCV in Pune.
Expectation from Paediatrians
An issue of reporting of referred case to neurologist for EMG/NCV in Pune
Should neurologist & EMG / NCV Labs also report this cases to PMC
An ethical issue
AFP Surveillance is in the end the only indicator for success
Cold Chain
OPV: unstable, but more stable than before and it can be monitored
Vaccine Vial Monitor (VVM)
1 = good OPV
2 = good OPV
3 = bad OPV 4 = bad OPV
Vaccine Vial Monitor (VVM)The square is lighter than the circle.
If the expiry date is not passed, use the vaccine
The square colour changes but lighter than the outer circle. If the expiry date is notpassed, use the vaccine
The square matches the circle. Do not use the vaccine.Inform your supervisor
The square is darker than the circle. Do not use the vaccine.Inform your supervisor
Thermal Characteristics of the Vaccine
OPV, Measles. : Heat Sensitive
VaccineDPT, DT, TT. : Freeze Sensitive
VaccineBCG : Light Sensitive
Vaccine
Recommended Temperature for Storage of OPV & Measles Vaccine
Level Temperature Storage Time
Central Storage-200 C (-150 C to –250 C)
8 Months
State/ District Storage
-200 C (-150 C to –250 C)
3 months
PHC/Dispensary/NursingHome
+20 C to +80 C 1 Months
Transport +20 C to +80 C 1 week
Routine immunization
Plan of routine immunization for out reach areas
Ward wise out reach sessions planned Provision of giving vaccine to private
practitioner
mOPV1 Effects
• Humoral immunity:– Circulating antibodies will prevent paralytic
disease (individual protection)• Mucosal immunity:
– Secretory antibodies will prevent replication and excretion (community barrier to transmission)
• Rationale for mOPV1 effectiveness:– No interference from Sabin types 2 & 3– In tOPV, type 2 most immunogenic, will outgrow
types 1+3
REPORT EVERY CASE OF AFP
• REPORT TO• Dr.SUNIL TORE• IMMUNIZATION OFFICER• PUNE MUNICIPAL CORPORATION• CONTACT NO.• 9689931339• 9822912062• 020-24487700